Precision Medicine

Can Precision Medicine Close the Health Equity Gap?
Tech & Innovation Can Precision Medicine Close the Health Equity Gap?

Indigenous women-led organizations like CIELO are acting as essential bridges between the medical research community and the migrant populations of Southern California. This effort is central to the California Initiative to Advance Precision Medicine (CIAPM), which allocated a $1.69 million grant

Timing and Coinfection Drive Success of Influenza Lineages
Biotech & Bioprocessing Timing and Coinfection Drive Success of Influenza Lineages

The landscape of influenza infection is characterized by extreme heterogeneity, where many cells fail to produce a complete set of viral genes due to packaging errors. This fundamental challenge means that the survival of a specific viral lineage often depends more on the logistical circumstances

Disc Medicine’s Oral Porphyria Drug Succeeds in Phase 3 Trial
Management & Regulatory Disc Medicine’s Oral Porphyria Drug Succeeds in Phase 3 Trial

Following the successful validation of its mechanism in Phase 3 trials, bitopertin is now positioned as a potential standard of care for individuals suffering from light-induced skin hypersensitivity. For many years, patients living with erythropoietic protoporphyria have navigated a world where

Can DIGITS Solve the Mental Health Data Fragmentation Crisis?
Tech & Innovation Can DIGITS Solve the Mental Health Data Fragmentation Crisis?

Standardizing the digital information gathered from daily life provides a unique opportunity to refine the accuracy of algorithms used in computational psychiatry. For years, the psychiatric community has struggled with a paradox: while patients carry devices that record every heartbeat and sleep

Is Cancer Stemness the Key to Prostate Cancer Resistance?
Research & Development Is Cancer Stemness the Key to Prostate Cancer Resistance?

The clinical reality of lineage plasticity allows prostate cancer cells to survive treatment by shedding their identity and adopting forms that do not require androgen. This phenomenon presents a persistent challenge in oncology, as traditional therapies predominantly target the androgen receptor

Computational Drug Screening for Resistant Tuberculosis
Tech & Innovation Computational Drug Screening for Resistant Tuberculosis

The relentless evolution of Mycobacterium tuberculosis into multi-drug-resistant and extensively drug-resistant strains has created a critical gap that current therapeutic pipelines are unable to fill. This biological arms race has forced the scientific community to confront the limitations of

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later